Press release
US Polycystic Ovarian Syndrome Treatment Market to Represent a Value of US$ 313.2 Mn By the End of 2024
Read Report Overview @ https://www.persistencemarketresearch.com/market-research/us-polycystic-ovarian-syndrome-treatment-market.asp
The foremost growth inhibitor for polycystic ovary syndrome treatment market in the US is pending approval of drugs at the FDA. The US FDA continues to prolong the approval for drugs on polycystic ovary syndrome treatment. And, this has severely lowered the production of effective medicines, thereby impacting the adoption of PCOS treatment. Presently, no drugs have been approved by the FDA for direct treatment of PCOS. Physicians are thus providing drug prescriptions through off-label indications, which is incidentally diverting patients to generic drugs.
Titled as “Polycystic Ovary Syndrome Treatment Market: US Industry Analysis and Forecast, 2016-2024,” the report projects that in 2016, more than US$ 66 Mn worth of oral contraceptive drugs were consumed in the US polycystic ovary syndrome treatment market. Through 2024, oral contraceptives will be exhibiting a steady revenue growth at 5.3% CAGR, and will account for nearly one-third share of market value. Besides, the demand for insulin sensitizing agents is expected to close in on number of oral contraceptives consumed in the US PCOS treatment market during this forecast period. Furthermore, growing preference to advanced drugs will also boost the consumption of aromatase inhibitors & SERMs, revenues from which will reach US$ 49 Mn by 2024-end.
Request Report For TOC @ https://www.persistencemarketresearch.com/market-research/us-polycystic-ovarian-syndrome-treatment-market/toc
More than 47% of US polycystic ovary syndrome treatment market will be accounted by drug sales through hospital pharmacies. With hospitals as the largest distribution channel, nearly US$ 150 Mn worth of PCOS drugs will be sold through these pharmacies. Meanwhile, PCOS drug sales through e-commerce platforms are projected to showcase a value CAGR of 4.6%, higher than that of hospital pharmacies and other distribution channels such as fertility clinics, drug stores and over-the-top counters.
Key companies partaking in the growth of the US polycystic ovary syndrome treatment market include Sanofi, Novartis AG, Merck KGaA, Teva Pharmaceutical Industries Limited, and AstraZeneca plc.
Request To Sample Of Report @ https://www.persistencemarketresearch.com/samples/14317
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Polycystic Ovarian Syndrome Treatment Market to Represent a Value of US$ 313.2 Mn By the End of 2024 here
News-ID: 947344 • Views: …
More Releases from Persistence Market Research
Highly Visible Packaging Market to Reach US$82.6 Bn by 2031, Driven by 7.8% CAGR …
➤Overview of the Market
The global highly visible packaging market is gaining strong momentum as consumer behavior increasingly shifts toward products that offer both convenience and visual appeal. According to Persistence Market Research, the market is projected to grow from US$48.8 Bn in 2024 to US$82.6 Bn by 2031, reflecting a robust CAGR of 7.8% during the forecast period. Highly visible packaging is designed to enhance product visibility, often through features…
Cosmetics and Perfumery Glass Bottles Market to Reach US$37.2 Bn by 2031 with 5. …
➤Overview of the Market
The cosmetics and perfumery glass bottles market plays a vital role in the global packaging industry, catering to the rising demand for premium beauty and fragrance products. Glass bottles are preferred over plastic due to their luxurious appeal, durability, and recyclability, making them the go-to choice for cosmetic and perfume manufacturers. According to the latest study by Persistence Market Research, the global market is projected to grow…
Bakery Cases Market to Reach US$1.5 Bn by 2031, Expanding at 6.0% CAGR - Persist …
➤Overview of the Market
The bakery cases market plays an essential role in the global food retail and foodservice industry, as it ensures the safe display, preservation, and presentation of bakery products such as bread, cakes, pastries, and desserts. These cases are vital not only for extending the shelf life of baked goods but also for enhancing their visual appeal, which significantly influences consumer purchase behavior. As bakeries, cafés, supermarkets, and…
Mining Waste Management Market to Reach US$307.53 Bn by 2031, Driven by Sustaina …
➤Overview of the Market
The mining waste management market plays a crucial role in addressing one of the most pressing issues of the global mining industry: the sustainable disposal and utilization of mining by-products. These wastes include tailings, slag, and waste rock generated during mineral extraction and processing. With rising environmental concerns, stricter government regulations, and the growing need for responsible mining, the demand for structured waste management systems is on…
More Releases for PCOS
Polycystic Syndrome (PCOS) Market Expected to Reach USD 7.9 Billion by 2034
Polycystic Syndrome (PCOS) is a complex hormonal disorder affecting women of reproductive age, characterized by irregular menstrual cycles, excessive androgen levels, and polycystic ovaries. Beyond its reproductive implications, PCOS is closely linked to metabolic issues such as insulin resistance, obesity, and increased risk of type 2 diabetes and cardiovascular diseases.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70728
Over the past decade, growing awareness, improved diagnostic capabilities, and greater emphasis…
Empowering Women's Health: A New Era Dawns in the PCOS Therapeutics Market
Polycystic Ovarian Syndrome (PCOS) affects an estimated 8-13% of women of reproductive age worldwide, presenting a multifaceted challenge that spans hormonal imbalance, metabolic disruption, and reproductive health. Today, the PCOS therapeutics market stands at the forefront of medical innovation, as pharmaceutical companies, biotech startups, and academic researchers converge to address the unmet needs of millions of women. This industry outlines the latest trends, breakthrough therapies, and market dynamics shaping this…
Global Efforts to Address Polycystic Ovarian Syndrome (PCOS) Gain Momentum
The Polycystic Ovarian Syndrome (PCOS) Treatment Market is expected to grow from an estimated USD 3514.5 million in 2024 to USD 5546.3 million in 2033, at a CAGR of 5.20%. Global initiatives to raise awareness and address Polycystic Ovarian Syndrome (PCOS) are making significant strides in improving women's health. The World Health Organization (WHO) highlights PCOS as a critical health disorder due to its impact on reproductive health, metabolic well-being,…
Laser Hair Removal for PCOS: A Chicago Guide
Polycystic Ory Syndrome (PCOS) is a hormonal disorder that affects around 10% of women of reproductive age worldwide. PCOS leads to a range of symptoms like irregular menstrual cycles, insulin resistance, and more. The most challenging symptoms for many women with PCOS are excessive hair growth on their face, chest, and back. It's a condition known as hirsutism. Thanks to developments in laser hair removal Chicago https://vplaserhairremoval.com/laser-hair-removal-chicago-prices/ offers, individuals with…
Discover Optimal PCOS Fertility Health Today with Dr. Angela Potter
Learn the secrets to optimal PCOS fertility health and improve the chances of pregnancy
PORTLAND, OR - Polycystic ovarian syndrome (PCOS) is a condition often attributed to infertility, affecting more than five million women [https://www.endocrine.org/patient-engagement/endocrine-library/pcos] in the United States alone. Unfortunately, many women with PCOS are immediately pointed in the direction of in vitro fertilization (IVF) - a notoriously expensive procedure that does not guarantee a successful embryo transfer or pregnancy.…
PCOS Treatment Market Projected to Reach $6.84 Billion by 2034
According to a recent analysis by Fact.MR, the global (PCOS) treatments market is expected to experience significant growth in the coming years. This expansion is driven by several key factors: a rising incidence of PCOS, advancements in treatment methodologies, and a growing focus on women's health and wellness.
Get Free Sample Research Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10043
PCOS is one of the most prevalent endocrine disorders among women of reproductive age globally. It manifests through symptoms…
